Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-01
2006-08-01
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S039000
Reexamination Certificate
active
07084150
ABSTRACT:
Disclosed are prodrugs and analogs of buprenorphine.
REFERENCES:
patent: 4588580 (1986-05-01), Gale et al.
patent: 4806341 (1989-02-01), Chien et al.
patent: 5026556 (1991-06-01), Drust et al.
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5225199 (1993-07-01), Hidaka et al.
patent: 5240711 (1993-08-01), Hille et al.
patent: 5908846 (1999-06-01), Bungaard et al.
patent: 5968547 (1999-10-01), Reder et al.
patent: 6231866 (2001-05-01), Mann
patent: 6344212 (2002-02-01), Reder et al.
patent: 9619975 (1994-12-01), None
Imoto et al., Biol. Pharm. Bull., vol. 19 (2), pp. 263-267, 1996.
Stinchcomb et al, Pharmaceutical Research, vol. 12(10), pp. 1526-1529, 1995.
Boer F. Peter
Kupper Robert
Davidson Davidson and Kappel LLC
Davis Zinna N.
Euro-Celtique S.A.
LandOfFree
Analogs and prodrugs of buprenorphine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analogs and prodrugs of buprenorphine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analogs and prodrugs of buprenorphine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3716790